您当前的位置：
首页 >
文章列表页 >
Clinical Efficacy of Modified Huangqi Chifengtang in Treatment of IgA Nephropathy Patients and Exploration of Dose-effect Relationship of Astragali Radix
更新时间：2024-12-24
|

    • Clinical Efficacy of Modified Huangqi Chifengtang in Treatment of IgA Nephropathy Patients and Exploration of Dose-effect Relationship of Astragali Radix

    • “The latest research shows that the combination of modified Huangqi Chifeng Decoction and different doses of Huangqi has a dose-response relationship in the treatment of IgA nephropathy proteinuria. High doses of Huangqi have the best therapeutic effect and good safety.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 31, Issue 2, Pages: 9-16(2025)

    • DOI：10.13422/j.cnki.syfjx.20242026    

      CLC： R692;R287;R256

    • Published：20 January 2025，

      Published Online：11 September 2024，

      Received：13 June 2024，

    移动端阅览

  • SHI Xiujie,CHANG Meiying,SHI Yue,et al.Clinical Efficacy of Modified Huangqi Chifengtang in Treatment of IgA Nephropathy Patients and Exploration of Dose-effect Relationship of Astragali Radix[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(02):9-16. DOI： 10.13422/j.cnki.syfjx.20242026.

  •  
  •  

0

Views

2

下载量

0

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Comparison of Cultivated and Wild-simulated Astragali Radix Based on Traditional Quality Evaluation
Analysis on Sugar Spectrum Difference Between Wild-simulated and Transplanted Astragali Radix
Mechanism of Qi-invigorating and Blood-activating Therapy in Mediating Autophagy of Precancerous Lesions of Atrophic Gastritis by miR216b/Beclin1
Pharmacodynamic Material Basis of Astragali Radix and Angelicae Sinensis Radix Drug Pair in Supplementing Qi and Activating Blood Circulation
Astragali Radix Combined with Angelicae Sinensis Radix Inhibits Activation of Adventitial Fibroblasts in Rabbit Model of Intimal Hyperplasia via TGF-β1/Smad2 Signaling Pathway

Related Author

ZHAO Jiachen
WANG Yapeng
WANG Yihan
QIAN Jinxiu
DENG Aiping
NAN Tiegui
KANG Liping
ZHAN Zhilai

Related Institution

School of Pharmacy，Hubei University of Chinese Medicine
State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs， National Resource Center for Chinese Materia Medica， China Academy of Chinese Medical Sciences
Institute of Process Engineering，Chinese Academy of Sciences
Modern Research Center for Traditional Chinese Medicine（TCM），Key Laboratory of Chemical Biology and Molecular Engineering of Ministry of Education，Shanxi Key Laboratory of Active Constituents Research and Utilization of TCM，Shanxi University
Shaanxi University of Chinese Medicine
0